News & Analysis as of September 26, 2024

Biologics

+ Follow

A repository for the most well-read content on JD Supra at any given time, along with occasional roundups of popular content by specific topic. Also stop by for monthly recaps of hot articles for the previous... more +

EU Parliament Adopts SPC Reform Proposals: Clarifying the Protection Scope for Biologics

Jones Day on 7/1/2024

On February 28, 2024, following the European Commission's four 2023 proposals, the European Parliament adopted a legislative resolution on the amended proposal to create a Unitary Supplementary Protection Certificate ("USPC")...more

The First Biosimilar Disputes at the Unified Patent Court (UPC)

Venable LLP on 5/23/2024

As the era of biologics and biosimilar litigations heats up in the United States, Europe’s Unified Patent Court (UPC) is also taking center stage with the first two biosimilar disputes filed in March and April....more

Brussels Regulatory Brief: April 2024

K&L Gates LLP on 5/17/2024

Antitrust and Competition - European Commission Charges Company with Providing Incorrect, Incomplete, and Misleading Information During a Merger Control Proceeding - On 19 March 2024, the European Commission (Commission) sent...more

2019 Highlights in Canadian Life Sciences IP and Regulatory Law

Smart & Biggar on 1/10/2020

In 2019, Rx IP Update reported on a number of developments in Canadian life sciences IP and regulatory law. We review top developments below: 1) PMPRB: Amendments to Regulations will come into force July 1, 2020, court...more

4 Results

View per page

Page: of 1

Today's Popular Updates › European Union › Biologics

EU Parliament Adopts SPC Reform Proposals: Clarifying the Protection Scope for Biologics

The First Biosimilar Disputes at the Unified Patent Court (UPC)

Brussels Regulatory Brief: April 2024

2019 Highlights in Canadian Life Sciences IP and Regulatory Law

"My best business intelligence, in one easy email…"